Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Biochem ; 67(1): 143-53, 1997 Oct 01.
Article in English | MEDLINE | ID: mdl-9328848

ABSTRACT

The product of an integrated transgene provides a convenient and cell-specific reporter of intracellular protein catabolism in 103 muscle cells of the nematode Caenorhabditis elegans. The transgene is an in-frame fusion of a 5'-region of the C. elegans unc-54 (muscle myosin heavy-chain) gene to the lacZ gene of Escherichia coli [Fire and Waterston (1989): EMBO J 8:3419-3428], encoding a 146-kDa fusion polypeptide that forms active beta-galactosidase tetramers. The protein is stable in vivo in well-fed animals, but upon removal of the food source it is inactivated exponentially (t1/2 = 17 h) following an initial lag of 8 h. The same rate constant (but no lag) is observed in animals starved in the presence of cycloheximide, implying that inactivation is catalyzed by pre-existing proteases. Both the 146-kDa fusion polypeptide (t1/2 = 13 h) and a major 116-kDa intermediate (t1/2 = 7 h) undergo exponential physical degradation after a lag of 8 h. Degradation is thus paradoxically faster than inactivation, and a number of characteristic immunoreactive degradation intermediates, some less than one-third the size of the parent polypeptide, are found in affinity-purified (active) protein. Some of these intermediates are conjugated to ubiquitin. We infer that the initial proteolytic cleavages occur in the cytosol, possibly by a ubiquitin-mediated proteolytic pathway and do not necessarily inactivate the fusion protein tetramer.


Subject(s)
Caenorhabditis elegans/metabolism , Endopeptidases/metabolism , Recombinant Fusion Proteins/metabolism , beta-Galactosidase/metabolism , Animals , Caenorhabditis elegans/genetics , Cycloheximide/pharmacology , Escherichia coli/enzymology , Food Deprivation , Genes, Reporter , Kinetics , Muscles/cytology , Muscles/metabolism , Myosin Heavy Chains/genetics , Protein Synthesis Inhibitors/pharmacology , Recombinant Fusion Proteins/isolation & purification , Transgenes , Ubiquitins/metabolism , beta-Galactosidase/genetics , beta-Galactosidase/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...